Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Vaccine Safety and Immunogenicity in Healthy Adults
NCT00115986Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated influenza a vaccine A/H5N1 in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2005; status: completed.
02
Drugs
inactivated influenza a vaccine A/H5N1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00115986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115986.